Table 2. Correlation of centromere protein H (CENP-H) expression to clinicopathologic characteristics of patients with breast cancer.
| Characteristic | CENP-H expression [cases (%)] |
P | Spearman's r value | ||
| Low | High | ||||
| Age (years) | ≤45 | 69 (22.5) | 55 (17.9) | 0.508 | –0.006 |
| >45 | 104 (33.9) | 79 (25.8) | |||
| Clinical stage | I | 21 (39.4) | 14 (4.6) | 0.001 | 0.192 |
| II | 96 (31.3) | 50 (16.3) | |||
| III | 44 (14.3) | 46 (15.0) | |||
| IV | 12 (3.9) | 24 (7.8) | |||
| T classification | T1 | 41 (13.4) | 25 (8.1) | 0.032 | 0.123 |
| T2 | 92 (30.0) | 65 (21.2) | |||
| T3 | 33 (10.7) | 26 (8.5) | |||
| T4 | 7 (2.3) | 18 (5.9) | |||
| N classification | N0 | 80 (26.1) | 48 (15.6) | 0.018 | 0.135 |
| N1 | 66 (21.5) | 51 (16.6) | |||
| N2 | 22 (7.2) | 27 (8.8) | |||
| N3 | 5 (1.6) | 8 (2.2) | |||
| Distant metastasis | No | 168 (54.7) | 125 (40.7) | 0.112 | 0.091 |
| Yes | 5 (1.6) | 9 (2.9) | |||
| Ki-67 expression | Low | 121 (39.4) | 75 (24.4) | <0.001 | 0.241 |
| High | 40 (13.1) | 71 (23.1) | |||